Affinity and Specificity for Binding to Glycosaminoglycans Can Be Tuned by Adapting Peptide Length and Sequence.
chemokine
glycosaminoglycan
glycosaminoglycan-binding motif
heparan sulfate
heparin
hyaluronic acid
peptides
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
31 Dec 2021
31 Dec 2021
Historique:
received:
10
12
2021
revised:
23
12
2021
accepted:
28
12
2021
entrez:
11
1
2022
pubmed:
12
1
2022
medline:
12
2
2022
Statut:
epublish
Résumé
Although glycosaminoglycan (GAG)-protein interactions are important in many physiological and pathological processes, the structural requirements for binding are poorly defined. Starting with GAG-binding peptide CXCL9(74-103), peptides were designed to elucidate the contribution to the GAG-binding affinity of different: (1) GAG-binding motifs (i.e., BBXB and BBBXXB); (2) amino acids in GAG-binding motifs and linker sequences; and (3) numbers of GAG-binding motifs. The affinity of eight chemically synthesized peptides for various GAGs was determined by isothermal fluorescence titration (IFT). Moreover, the binding of peptides to cellular GAGs on Chinese hamster ovary (CHO) cells was assessed using flow cytometry with and without soluble GAGs. The repetition of GAG-binding motifs in the peptides contributed to a higher affinity for heparan sulfate (HS) in the IFT measurements. Furthermore, the presence of Gln residues in both GAG-binding motifs and linker sequences increased the affinity of trimer peptides for low-molecular-weight heparin (LMWH), partially desulfated (ds)LMWH and HS, but not for hyaluronic acid. In addition, the peptides bound to cellular GAGs with differential affinity, and the addition of soluble HS or heparin reduced the binding of CXCL9(74-103) to cellular GAGs. These results indicate that the affinity and specificity of peptides for GAGs can be tuned by adapting their amino acid sequence and their number of GAG-binding motifs.
Identifiants
pubmed: 35008874
pii: ijms23010447
doi: 10.3390/ijms23010447
pmc: PMC8745253
pii:
doi:
Substances chimiques
Heparin, Low-Molecular-Weight
0
Peptides
0
Heparitin Sulfate
9050-30-0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Research Foundation - Flanders
ID : 1S50018N
Organisme : Research Foundation - Flanders
ID : 11A4220N
Organisme : Onderzoeksraad, KU Leuven
ID : C16/17/010
Références
Blood. 2002 Dec 1;100(12):3853-60
pubmed: 12433694
Cell Mol Life Sci. 2021 Nov;78(21-22):6963-6978
pubmed: 34586443
Arch Biochem Biophys. 1995 Nov 10;323(2):279-87
pubmed: 7487089
J Biol Chem. 2004 Mar 26;279(13):12598-604
pubmed: 14707146
PLoS One. 2012;7(8):e42692
pubmed: 22880084
Annu Rev Biochem. 2002;71:435-71
pubmed: 12045103
Cancers (Basel). 2021 Oct 12;13(20):
pubmed: 34680238
Angew Chem Int Ed Engl. 2002 Feb 1;41(3):391-412
pubmed: 12491369
Front Immunol. 2017 May 10;8:530
pubmed: 28539925
Pharmaceuticals (Basel). 2017 Aug 09;10(3):
pubmed: 28792472
J Pharmacol Exp Ther. 1997 Jul;282(1):208-19
pubmed: 9223556
Biochim Biophys Acta. 2005 Feb 21;1687(1-3):52-63
pubmed: 15708353
Glycobiology. 2015 Sep;25(9):976-83
pubmed: 26033936
Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1549-57
pubmed: 15231514
PLoS One. 2008 Jul 02;3(7):e2543
pubmed: 18648536
Nat Methods. 2018 Nov;15(11):881-888
pubmed: 30104636
Mol Biosyst. 2017 May 2;13(5):852-865
pubmed: 28317949
J Biol Chem. 2000 Mar 17;275(11):7701-7
pubmed: 10713081
Front Mol Biosci. 2021 Mar 09;8:639666
pubmed: 33768117
J Immunol. 2018 May 1;200(9):3201-3217
pubmed: 29572348
Arteriosclerosis. 1989 Jan-Feb;9(1):21-32
pubmed: 2463827
J Biol Chem. 1992 May 5;267(13):8857-62
pubmed: 1577724
J Biol Chem. 1999 Sep 10;274(37):26165-71
pubmed: 10473568
Molecules. 2021 Sep 10;26(18):
pubmed: 34576979
Front Immunol. 2020 Mar 31;11:483
pubmed: 32296423
Biochemistry. 2002 Feb 5;41(5):1640-6
pubmed: 11814358
J Histochem Cytochem. 2021 Feb;69(2):93-104
pubmed: 32757871
J Biol Chem. 2004 May 21;279(21):22294-305
pubmed: 15033992
Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14683-8
pubmed: 9405673
Immunol Cell Biol. 2015 Apr;93(4):372-83
pubmed: 25708536
Methods Enzymol. 2009;461:3-29
pubmed: 19480912
ACS Chem Biol. 2015 May 15;10(5):1303-10
pubmed: 25680304
Chem Biol Drug Des. 2008 Dec;72(6):455-82
pubmed: 19090915
Biotechnol Prog. 2018 May;34(3):602-612
pubmed: 29693321
Bioessays. 1998 Feb;20(2):156-67
pubmed: 9631661
Molecules. 2014 Jul 22;19(7):10618-34
pubmed: 25054442
Biochem Pharmacol. 2016 Jan 15;100:73-85
pubmed: 26551597
J Leukoc Biol. 2018 Aug;104(2):413-422
pubmed: 29733455
J Biol Chem. 1987 Sep 5;262(25):12189-95
pubmed: 2957376
Methods Enzymol. 2009;461:71-102
pubmed: 19480915
Annu Rev Biochem. 2014;83:129-57
pubmed: 24606135
J Biol Chem. 2015 Aug 28;290(35):21292-304
pubmed: 26183778
Clin Exp Allergy. 2018 Oct;48(10):1333-1344
pubmed: 29978510